Simplex Trading
BEAM icon

Simplex Trading’s Beam Therapeutics BEAM Stock Holding History

Simplex Trading’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Sell
3,800
-8,800
-70% -$266K ﹤0.01% 5236
2026
Q1 		$300K Buy
12,600
+2,100
+20% +$58.3K ﹤0.01% 3820
2025
Q4 		$291K Sell
10,500
-15,400
-59% -$393K ﹤0.01% 3850
2025
Q3 		$628K Sell
25,900
-62,100
-71% -$1.24M ﹤0.01% 3551
2025
Q2 		$1.5M Buy
88,000
+60,300
+218% +$1.05M ﹤0.01% 2380
2025
Q1 		$540K Buy
27,700
+18,300
+195% +$479K ﹤0.01% 3322
2024
Q4 		$233K Buy
9,400
+5,600
+147% +$143K ﹤0.01% 4359
2024
Q3 		$93K Sell
3,800
-35,800
-90% -$925K ﹤0.01% 5305
2024
Q2 		$927K Sell
39,600
-12,500
-24% -$307K ﹤0.01% 2991
2024
Q1 		$1.72M Buy
52,100
+43,900
+535% +$1.37M ﹤0.01% 2560
2023
Q4 		$223K Sell
8,200
-33,100
-80% -$822K ﹤0.01% 4563
2023
Q3 		$993K Buy
41,300
+36,600
+779% +$981K ﹤0.01% 2663
2023
Q2 		$150K Sell
4,700
-51,400
-92% -$1.67M ﹤0.01% 4621
2023
Q1 		$1.72M Buy
56,100
+38,000
+210% +$1.5M ﹤0.01% 2072
2022
Q4 		$707K Buy
18,100
+6,400
+55% +$287K ﹤0.01% 2819
2022
Q3 		$557K Sell
11,700
-6,000
-34% -$342K ﹤0.01% 3348
2022
Q2 		$685K Buy
17,700
+4,300
+32% +$171K ﹤0.01% 3064
2022
Q1 		$767K Buy
13,400
+12,400
+1,240% +$813K ﹤0.01% 3261
2021
Q4 		$79K Sell
1,000
-7,400
-88% -$634K ﹤0.01% 6597
2021
Q3 		$1.12M Sell
8,400
-100
-1% -$10K ﹤0.01% 2901
2021
Q2 		$1.09M Buy
8,500
+8,437
+13,392% +$672K ﹤0.01% 2972
2021
Q1 		$504K Buy
63
+1
+2% +$95 ﹤0.01% 3363
2020
Q4 		$506K Buy
+62
New +$3.05K ﹤0.01% 3403

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Simplex Trading's BEAM Position: Q2 2026 in Review

Simplex Trading increased its Beam Therapeutics (BEAM) stake by 546% in Q2 2026, buying an estimated $216K and bringing the position to 8,450 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #4265.

Simplex Trading first reported a position in BEAM in Q4 2021 and has held it in 14 quarters since. The position peaked at $962K in Q2 2025. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Simplex Trading held 8,450 shares of Beam Therapeutics worth $290K as of Q2 2026.
  • Simplex Trading bought 7,142 Beam Therapeutics shares in Q2 2026, an estimated $216K.
  • Beam Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4265 holding.
  • Simplex Trading first reported a position in Beam Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • Simplex Trading's Beam Therapeutics position peaked at $962K in Q2 2025.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.